U.S. lawmakers press Heritage Pharma on high prices for antibiotic
Source: Reuters
POLITICS | Fri Dec 16, 2016 | 5:40pm EST
U.S. lawmakers press Heritage Pharma on high prices for antibiotic
By Sarah N. Lynch | WASHINGTON
Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing.
In a Dec. 16 letter to Heritage seen by Reuters, Maryland Democratic Representative Elijah Cummings and Vermont Independent Senator Bernie Sanders said they feared the company was "disingenuous at best" in October 2014 when it told them it had not seen any significant price increases for its doxycycline hyclate product.
"We are very concerned that you made these assertions to Congress on behalf of Heritage during the exact time period that its executives were engaged in a price fixing scheme to prevent competition from driving down prices of doxycycline hyclate," they wrote.
In response to Friday's letter, the company said it does not make the same version of doxycycline hyclate that the lawmakers asked about in 2014. Heritage makes a delayed release version, not the immediate release version that was the subject of the 2014 inquiry.
[font size=1]
-snip-[/font]
Read more:
http://www.reuters.com/article/us-usa-pharmaceuticals-congress-idUSKBN1452RU